Literature DB >> 8621766

Nitric oxide inhibits viral replication in murine myocarditis.

C J Lowenstein1, S L Hill, A Lafond-Walker, J Wu, G Allen, M Landavere, N R Rose, A Herskowitz.   

Abstract

Nitric oxide (NO) is a radical molecule that not only serves as a vasodilator and neurotransmitter but also acts as a cytotoxic effector molecule of the immune system. The inducible enzyme making NO, inducible NO synthase (iNOS), is transcriptionally activated by IFN-gamma and TNF-alpha, cytokines which are produced during viral infection. We show that iNOS is induced in mice infected with the Coxsackie B3 virus. Macrophages expressing iNOS are identified in the hearts and spleens of infected animals with an antibody raised against iNOS. Infected mice have increased titers of virus and a higher mortality when fed NOS inhibitors. Thus, viral infection induces iNOS in vivo, and NO inhibits viral replication. NO is a novel, nonspecific immune defense against viruses in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621766      PMCID: PMC507251          DOI: 10.1172/JCI118613

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis.

Authors:  H Esumi; S R Tannenbaum
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

2.  Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists.

Authors:  D Ungureanu-Longrois; J L Balligand; W W Simmons; I Okada; L Kobzik; C J Lowenstein; S L Kunkel; T Michel; R A Kelly; T W Smith
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

3.  Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide.

Authors:  C J Lowenstein; E W Alley; P Raval; A M Snowman; S H Snyder; S W Russell; W J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

5.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils.

Authors:  X F Niu; C W Smith; P Kubes
Journal:  Circ Res       Date:  1994-06       Impact factor: 17.367

7.  Induction of myocardial nitric oxide synthase by cardiac allograft rejection.

Authors:  X Yang; N Chowdhury; B Cai; J Brett; C Marboe; R R Sciacca; R E Michler; P J Cannon
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients.

Authors:  P Dighiero; I Reux; J J Hauw; A M Fillet; Y Courtois; O Goureau
Journal:  Neurosci Lett       Date:  1994-01-17       Impact factor: 3.046

9.  Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes.

Authors:  J P Bolaños; S Peuchen; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

10.  Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication.

Authors:  N Harris; R M Buller; G Karupiah
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more
  52 in total

Review 1.  Antioxidant and other activities of phenolics in olives/olive oil, typical components of the Mediterranean diet.

Authors:  C Galli; F Visioli
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells.

Authors:  R Friedl; T Moeslinger; B Kopp; P G Spieckermann
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 4.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

5.  Gaseous Nitric Oxide and Dinitrosyl Iron Complexes with Thiol-Containing Ligands as Potential Medicines that Can Relieve COVID-19.

Authors:  A F Vanin; A V Pekshev; A B Vagapov; N A Sharapov; V L Lakomkin; A A Abramov; A A Timoshin; V I Kapelko
Journal:  Biophysics (Oxf)       Date:  2021-04-27

6.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Authors:  K Lind; E Svedin; R Utorova; V M Stone; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.

Authors:  Roland Zell; René Markgraf; Michaela Schmidtke; Matthias Görlach; Axel Stelzner; Andreas Henke; Holger H Sigusch; Brigitte Glück
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

9.  Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon.

Authors:  M S Horwitz; T Krahl; C Fine; J Lee; N Sarvetnick
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.

Authors:  N Fujioka; R Akazawa; K Ohashi; M Fujii; M Ikeda; M Kurimoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.